MagVenture’s depression treatment – the MagVita TMS Therapy®- is CE approved for “treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode”.

 

A full depression treatment for patients who have been properly diagnosed and found suitable for rTMS depression treatment includes an initial session with Motor Threshold (MT) determination, followed by 5 treatment sessions per week during a period of normally 4-6 weeks.

MagVenture’s treatment protocol consists of 3.000 brief pulses delivered with a repetition rate of 10 pulses per second in 4-second “trains” with 26-second pauses between “trains”. This 37-minutes procedure is pre-programmed as the standard treatment protocol in MagVenture’s system.

MagVenture’s depression system includes the following three steps:

1. Treatment cap selection and positioning

2. Motor Threshold determination (MT)

3. Treatment Session

Motor Threshold Determination has two purposes: to determine the location of the hand area of the motor cortex and to determine stimulation level. Once the motor cortex is found, a line is drawn on the patient’s individual cap to show the operator where to place the coil when performing the actual depression treatments.

MT determination should only be performed by medically skilled people. The MT determination is performed on the left hemisphere because the subsequent depression treatments are performed over the left dorsolateral prefrontal cortex (DLPFC). When performing rTMS depression treatment, the stimulation level is defined as 120 % of MT.

 Read the story bellow by clicking the link:

http://www.magventure.com/en-gb/depression-treatment-with-rTMS